tiprankstipranks
Trending News
More News >
Guard Therapeutics International AB (DE:5LH0)
FRANKFURT:5LH0
Germany Market

Guard Therapeutics International AB (5LH0) Income Statement

Compare
1 Followers

Guard Therapeutics International AB Income Statement

Last quarter (Q4 2024), Guard Therapeutics International AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Guard Therapeutics International AB's net income was kr-25.96M. See Guard Therapeutics International AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr -15.00Kkr -15.00Kkr -15.00Kkr -161.00Kkr -290.00K
Operating Expenses
kr 115.07Mkr 113.63Mkr 81.28Mkr 40.28Mkr 44.28M
Depreciation and Amortization
kr 15.00Kkr 15.00Kkr 15.00Kkr 161.00Kkr 290.00K
EBITDA
kr -114.91Mkr -112.82Mkr -82.01Mkr -40.12Mkr -43.29M
Operating Income
kr -115.07Mkr -114.92Mkr -81.90Mkr -40.28Mkr -44.28M
Other Income/Expenses
kr 1.75Mkr 2.08Mkr -130.00Kkr -7.00Kkr -872.00K
Pretax Income
kr -113.32Mkr -112.84Mkr -82.03Mkr -40.28Mkr -45.16M
Net Income
kr -113.32Mkr -110.76Mkr -82.16Mkr -40.29Mkr -46.03M
Per Share Metrics
Basic EPS
kr -11.26kr -15.72kr -18.41kr -12.15kr -22.16
Diluted EPS
kr -11.26kr -15.72kr -18.41kr -12.15kr -22.16
Weighted Average Shares Outstanding
10.06M 7.05M 4.46M 3.32M 2.08M
Weighted Average Shares Outstanding (Diluted)
10.06M 7.05M 4.46M 3.32M 2.08M
Currency in SEK

Guard Therapeutics International AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis